Brief: Medicure Announces FDA Approval Of Sodium Nitroprusside Injection

Medicure

13/08/2018 19:55

Aug 13 (Reuters) - Medicure Inc  MPH.V :
    * MEDICURE ANNOUNCES FDA APPROVAL OF ACUTE CARE
CARDIOVASCULAR
DRUG SODIUM NITROPRUSSIDE INJECTION
    * MEDICURE - FDA APPROVED ANDA FOR SODIUM NITROPRUSSIDE
INJECTION
50 MG/2 ML SINGLE DOSE VIAL
    * MEDICURE - NEWLY APPROVED PRODUCT WAS DETERMINED BY FDA TO
BE
THERAPEUTICALLY EQUIVALENT TO NITROPRESS

Source text for Eikon:  ID:nCNWzWrxFa 
Further company coverage:  MPH.V 

 ((Reuters.Briefs@thomsonreuters.com;))